Study guide

7.4 Digital Publication Features, Accessibility, and Social Dissemination

Certified Medical Publication Professional CMPP

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Preparation Strategy

1.1 ISMPP CMPP Certification Overview, Eligibility & Exam Format 1.2 Recertification, Continuing Education (CE) Credits & ISMPP U 1.3 Core Reference Hierarchy, Primary Documents & Test-Taking Strategy

2 Chapter 2: Publication Planning: Strategy, Environment & Scientific Platform

2.1 Medical Publication Lifecycle & Strategic Planning Frameworks 2.2 Therapeutic Landscape Analysis, Unmet Needs & Gap Analysis 2.3 Scientific Communication Platforms and Evidence-Based Language

3 Chapter 3: Publication Planning: Governance, Steering Committees & Venue Selection

3.1 Publication Steering Committees: Charters, Roles & Scientific Governance 3.2 Target Audience Identification: HCPs, Patients, Payers & Regulators 3.3 Venue Selection, Open Access, and Congress Strategy

4 Chapter 4: Publication Planning: Operations, Contracting, Global Alignment & Compliance

4.1 Publication Agreements, Review Rights, Compensation & Disclosure 4.2 Milestones, Gantt Charts, Budgeting & Vendor/Agency Management 4.3 Global vs. Regional/Local Publication Alignment & Localization 4.4 Publication SOPs, Documentation, Quality Control & Audit Readiness

5 Chapter 5: Reporting Guidelines: Foundational Standards & Trial Reporting

5.1 EQUATOR and Design-Specific Reporting Guidelines 5.2 CONSORT 2025 & Flow Diagrams for Randomized Trials 5.3 SPIRIT 2025: Standard Protocol Items for Interventional Trials

6 Chapter 6: Reporting Guidelines: Observational, Reviews & Preclinical

6.1 PRISMA 2020 for Systematic Reviews & Meta-Analyses 6.2 STROBE & RECORD for Observational and Routinely Collected Data 6.3 ARRIVE 2.0 for In Vivo Animal Research

7 Chapter 7: Specialized Reporting, Plain Language Summaries & Congress Submissions

7.1 STARD 2015, CARE, and Specialized Reporting Guidelines 7.2 Plain-Language Summaries and Patient Partnership 7.3 GPCAP 2026: Congress Abstracts, Presentations & Encores 7.4 Digital Publication Features, Accessibility, and Social Dissemination

8 Chapter 8: Manuscript Lifecycle: Drafting, Peer Review, Open Access & Metrics

8.1 Manuscript Development, Author Review, and Sponsor Boundaries 8.2 Peer Review, Rebuttals, Revisions, and Appeals 8.3 Preprints, Creative Commons & Current Open-Access Requirements 8.4 Post-Publication Metrics and Correcting the Record

9 Chapter 9: Ethical Principles: GPP 2022, Authorship Criteria & Contributorship

9.1 Good Publication Practice 2022: Principles, Scope & Application 9.2 ICMJE Authorship Criteria and Qualification Scenarios 9.3 Nonauthor Contributors, Acknowledgments, and CRediT

10 Chapter 10: Ethics & Transparency: Ghostwriting, Writing Assistance, COI & Disclosure

10.1 Ghostwriting, Guest Authorship, and Authorship Disputes 10.2 Professional Medical Writing: Roles, Authorship, Disclosure & Funding 10.3 Disclosure of Interests and Publication Transparency 10.4 Open Payments, EFPIA Codes & Publication-Related Transfers of Value

11 Chapter 11: Compliance & Legal: Clinical Trial Registration, Data Sharing, Regulatory & Ethics

11.1 Trial Registration and Results Disclosure: US, EU, and ICMJE 11.2 Clinical-Trial Data-Sharing Statements and FAIR Principles 11.3 FDA SIUU Guidance & Promotional/Scientific Communication Boundaries 11.4 2024 Declaration of Helsinki, Ethics Review, Privacy & Copyright

7.4 Digital Publication Features, Accessibility, and Social Dissemination

Key Takeaways Explain This Topic AI

A visual abstract, infographic, video, podcast, or interactive feature must faithfully represent the parent evidence and must not promote an exploratory finding into a primary conclusion.

The venue determines review, hosting, metadata, identifier, file, accessibility, and licensing requirements; neither formal peer review nor a separate DOI is universal for every enhanced asset.

Accessibility is part of quality: plan captions, transcripts, meaningful alternative text, contrast, legible typography, keyboard access where applicable, and non-color cues.

Public sharing is fact- and jurisdiction-specific; assess product status, audience, content, branding, surrounding context, platform, personnel, and applicable law or code rather than applying a universal “unbranded” rule.

A Creative Commons license states permissions and conditions; CC BY permits commercial reuse with attribution, while CC BY-NC adds a noncommercial restriction but does not guarantee technical permanence or prevent infringement.

Last updated: October 2026

Digital Publication Features, Accessibility, and Social Dissemination

Digital features can help readers understand and find research, but the format does not lower the scientific standard. A visual abstract, infographic, video abstract, podcast, interactive figure, animation, or social card should communicate the parent work without changing its evidentiary weight.

Start with the parent evidence

Create an approved source map linking every number, claim, and visual element to the manuscript, tables, figures, supplement, or another clearly identified source. Preserve the study population, comparator, endpoint definition, analysis set, time point, and uncertainty. Label post hoc, subgroup, interim, modeled, and nonrandomized results accurately.

A digital asset should not:

  • call an exploratory subgroup the study's main result;
  • replace an adjusted estimate with an incompatible crude percentage;
  • crop an axis or omit a denominator in a way that exaggerates effect;
  • present “not statistically significant” as proof of equivalence;
  • omit important safety or limitations while highlighting benefit;

introduce a claim, image, quotation, or call to action that makes the overall communication promotional or misleading.

If the asset is created after acceptance, check the final version rather than an obsolete submitted draft. Maintain version control so later corrections to the article can be propagated to linked assets.

Venue requirements control the workflow

Journals and congresses differ. One may peer review a video with the article, another may perform editorial or production review, and another may host author-provided material with a disclaimer. An asset may share the article DOI, receive a related persistent identifier, or have no separate DOI. Hosting may be on the journal platform, a repository, a conference site, or another approved service.

Therefore, do not teach that every enhanced asset must receive formal peer review, its own DOI, direct journal hosting, and a Creative Commons license. Instead, verify:

  • allowed format, length, dimensions, and file type;
  • whether submission is optional or required;
  • review and approval process;
  • article and asset linking or identifier rules;
  • embargo and release timing;
  • copyright ownership and third-party permissions;
  • license, repository, retention, and correction policy;
  • accessibility specifications;

disclosure of funding, writing, editing, animation, or production support.

The current GPCAP principles reinforce accurate, ethical, accessible congress presentations, including enhanced content, but the individual venue's instructions remain controlling.

Accessibility by design

Accessibility is more than adding an “alt text” field at the end. Plan it during scripting and design:

provide accurate captions and a transcript for audio or video;

write alternative text that conveys the information and function of a visual rather than repeating its caption;

  • use sufficient contrast and legible type at the expected display size;
  • avoid color as the only distinction between groups;
  • define abbreviations and minimize unexplained icons;
  • support keyboard operation and logical focus order for interactive content where applicable;
  • avoid flashing or motion that creates access or safety problems;

test the exported file, not only the editable source.

A complex chart may require a short alt description plus an adjacent data table or long description. Accessibility requirements may arise from the platform, institution, contract, or law, so consult the applicable standard rather than claiming one checklist covers every format.

Licensing and permanence

A DOI is an identifier supported by a registration and resolution system; it is not a copyright license and does not itself promise that a file can never disappear. Repository governance, preservation practices, metadata, and version control matter.

Creative Commons licenses answer a different question: what reuse is authorized?

CC BY permits sharing and adaptation, including commercial reuse, if its conditions such as attribution and indication of changes are met.

CC BY-NC limits licensed reuse to noncommercial purposes; borderline uses may require interpretation or permission.

CC BY-ND allows redistribution under its terms but does not authorize distribution of adaptations.

CC0 is a public-domain dedication to the extent possible.

A license does not prevent misuse; it supplies permissions and enforceable conditions. It also cannot grant rights the licensor does not own. Check third-party figures, music, patient images, trademarks, and privacy or consent restrictions separately.

Social dissemination requires contextual review

Sharing an article or visual through a company or employee account can raise scientific, advertising, securities, privacy, pharmacovigilance, and platform questions. The analysis depends on:

  • product authorization and indication;
  • audience and geographic reach;
  • exact text, image, balance, links, and call to action;
  • brand and generic naming;
  • whether the communication is firm initiated;
  • whether the content discusses an unapproved use;
  • the role and account of the person posting;

local law, industry code, and company procedure.

Some public prescription-medicine promotion is prohibited in many non-US jurisdictions. That does not create one global rule that every scientific post must be “unbranded,” and US availability of direct-to-consumer advertising does not make every branded post compliant. Geotargeting, gated access, links, comments, reposts, and the surrounding account can affect the overall impression. Route the final proposed communication through the applicable review process.

Metrics without overclaiming impact

Downloads, views, completion rates, shares, mentions, news attention, citations, and policy references measure different behaviors. Altmetric or PlumX indicators may show attention; they do not establish scientific quality, favorable sentiment, clinical adoption, or patient benefit. Define the question first, use the relevant metric and time window, and document platform limitations such as bots, duplicate events, changing algorithms, and missing demographic information.

Important

The exam-safe rule is evidence fidelity plus venue and jurisdiction specificity. Reject an answer that assumes all digital assets follow one DOI, license, review, or social-media pathway.